- Trinity Biotech (TRIB -3.1%) Q2: Diluted EPS (ex-Medical Devise Excise Tax) of $0.176.
- Revenue of $21.3M (+2.4% Y/Y) misses by $0.7M.
- The company also says it is acquiring Immco Diagnostics for $32.75M, a deal TRIB says will be "immediately earnings accretive." (PR)
Next headline on your portfolio: